QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression
This study is ongoing, but not recruiting participants.
Study NCT00480363
Information provided by PETHEMA Foundation
First Received on May 28, 2007.
Last Updated on June 15, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
